Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|January 9, 2026
GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studiesDario Giugliano, Miriam Longo, Nicole Di Martino, et al.
Cardiovascular Diabetology|July 7, 2026
Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studiesPaola Caruso, Nicole Di Martino, Miriam Longo, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept StudyMiriam Longo, Erika Paolini, Marica Meroni, et al.
Diabetes Care|April 22, 2020
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled TrialsMaria Ida Maiorino, Simona Signoriello, Antonietta Maio, et al.
Cardiovascular Diabetology|September 16, 2021
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTsDario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Frontiers in Nutrition|October 3, 2022
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemiaMarica Meroni, Miriam Longo, Erika Paolini, et al.
Diabetes Research and Clinical Practice|September 14, 2020
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in ItalyMiriam Longo, Paola Caruso, Michela Petrizzo, et al.
The Journal of Sexual Medicine|November 23, 2020
Female Sexual Function in Young Women With Type 1 Diabetes and Additional Autoimmune DiseasesMiriam Longo, Paolo Cirillo, Lorenzo Scappaticcio, et al.
Pharmacological Reports : PR|May 28, 2026
Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance databaseAntonietta Anatriello, Valerio Liguori, Ciro Pentella, et al.
Endocrine|October 3, 2023
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetesDario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Pageof 13